Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial

Conclusion: Oral verapamil can decrease paroxysmal supraventricular tachycardia recurrence after successful control with intravenous adenosine.

http://tak.sagepub.com/cgi/content/abstract/9/1/4?rss=1

Source: Therapeutic Advances in Cardiovascular Disease - January 13, 2015 Category: Cardiology Authors: Shaker, H., Jahanian, F., Fathi, M., Zare, M. Tags: Original Research Source Type: research